We collaborate with the world for the health of everyone in it.Learn more
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we envision a world without disease. To achieve this, we strive to couple our strong internal capabilities with the most compelling external science to transform how diseases are thought of being treated, cured, prevented and intercepted in the future.
Our Pharmaceuticals business is divided into five core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; and Oncology. We seek innovation across all of these areas where there is significant unmet patient need.CLICK a circle below to see the diseases we are targeting.
Type 2 DiabetesCardiovascular and Metabolism
Psoriasis, Inflammatory Bowel Disease, Rheumatoid ArthritisImmunology
Respiratory Infections, HepatitisInfectious
Diseases and Vaccines
Mood Disorders, Alzheimer's DiseaseNeuroscience
Prostate Cancer, Lung Cancer, Hematologic MalignanciesOncology
Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities.
If you are seeking incubation space for your early-stage company, or seeking to expand your start-up through an exchange of ideas and collaboration, make the connection with our incubation teams.
If you are with a consumer, medical device or biopharmaceutical company and seek a strategic venture partner, make the connection with our Johnson & Johnson Innovation – JJDC, Inc. team.
Make the Connection
We look forward to our first discussion. If you would like to discuss a collaboration,
please connect with us and we will schedule a call soon.